Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era
Authors:
- 1 May 2016
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (13) , 1443-1447
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphomaLeukemia & Lymphoma, 2011
- Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysisAnnals of Oncology, 2011
- Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort studyHaematologica, 2008
- Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014Journal of Clinical Oncology, 2008
- Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directionsNature Clinical Practice Oncology, 2007
- CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’AdulteJournal of Clinical Oncology, 2007
- The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphomaCancer, 2006
- Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort StudyJournal of Clinical Oncology, 2006
- Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484Journal of Clinical Oncology, 2004